CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 301563-301869 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","sourcedb":"CORD-19","sourceid":"3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","text":"Also in development are two additional carbapenems, ME1036, in Phase I studies, with activity against MRSA as well as against most Enterobacteriaceae, and SMP-601/PZ-601 that has demonstrated in vitro activity against many multidrug-resistant Gram-positive and Gramnegative bacteria in preclinical studies.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2320","span":{"begin":0,"end":306},"obj":"Sentence"},{"id":"T58231","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T2320","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T58231","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T56","span":{"begin":0,"end":306},"obj":"Sentence"}],"attributes":[{"subj":"T56","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1038","span":{"begin":102,"end":106},"obj":"Disease"},{"id":"T10029","span":{"begin":102,"end":106},"obj":"Disease"}],"attributes":[{"id":"A1038","pred":"mondo_id","subj":"T1038","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A63287","pred":"mondo_id","subj":"T10029","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"subj":"T1038","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T10029","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93a1","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93bbec"},{"id":"CORD-19-PD-MONDO","color":"#d5ec93"}]}]}}